Sanofi, GSK to supply 60 million doses of COVID-19 vaccine to UK
Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to 60 million doses of their jointly developed ... Read More
Sanofi to build new $396m vaccine manufacturing facility in Toronto
Significant Investment in Vaccine Production: French pharmaceutical giant Sanofi has announced plans to invest CAD 500 million (approximately $396.3 million) to construct a new vaccine ... Read More
AstraZeneca and Sanofi Pasteur forge €615m alliance to develop infant respiratory drug MEDI8897
AstraZeneca’s biotech arm, MedImmune, and Sanofi Pasteur, the vaccines division of French pharmaceutical giant Sanofi, have entered into a significant research and development collaboration. The ... Read More
Dengvaxia : Sanofi Pasteur rolls out world’s first dengue vaccine in Guatemala
Sanofi Pasteur, the French pharmaceutical giant, has announced the rollout of Dengvaxia, the world's first dengue vaccine, in Guatemala in the upcoming days. This significant ... Read More
Amgen’s Parsabiv receives EC approval in secondary hyperparathyroidism
Amgen Inc., a leading American biopharmaceutical company, has achieved a significant milestone with the approval of its drug Parsabiv (etelcalcetide) by the European Commission (EC) ... Read More